The data in this table refer to pregnancies from oocyte retrieval (pick-up) that have reached term achieved by means of HOMOLOGOUS MAR; all pregnancies that have started but have not resulted in a birth have been deliberately excluded, thus differentiating us from those clinics that report results for total pregnancies and thus include miscarriages.
This choice was made to inform couples of the real possibility of giving birth to a child with a single IVF-ICSI cycle of treatment.
| Age | % PARTS by Age |
| ≤ 34 | 62.10 |
| 35-36 | 52.23 |
| 37-40 | 40.06 |
| 41-42 | 23.07 |
| › 42 | 6.41 |
| Totale | 37.01 |
Age is a very important factor in treatment success rates. Customising hormone stimulation by adapting it to the needs of each patient and access to a state-of-the-art in-vitro fertilisation laboratory, where embryos develop in the best possible conditions, allows the CMR to achieve very high success rates above the national average , even in patients of advanced maternal age.
Part rates per pick-up performed recorded by age group of patients updated to 2021 in Italy.
It should be noted that the data relate to pregnancies achieved and not to children born, as reported in our tables.
| Age | % parts x pick-up |
| ≤ 34 | 37,3% |
| 35-39 | 26,3% |
| 40-42 | 11,9% |
| ≥ 42 | 4,8% |
| Tot | 24,0% |
In recent decades, motherhood has been increasingly postponed, especially in Italy, where fewer and fewer women manage to have a child between the ages of 28 and 35. Egg donation today represents the assisted fertilisation technique with the highest probability of success, precisely because by using a donor of a young age (20-35), it is possible to overcome the main factor of infertility, which is maternal age.
In CMR, the percentage of positive results with a single egg donation cycle is 72%.
PARTS OBTAINED FROM THE CMR CENTRE
AN EGG DONATION CYCLE
MEDIA PARTS IN ITALY
AN EGG DONATION CYCLE
Extremely advanced laboratory procedures (blastocyst culture and pre-implantation genetic testing) aim to provide invaluable information on the viability and genetic make-up of the embryo, so as to identify that with the greatest implantation potential and with the minimum risk of miscarriage after transfer to the uterus.
The figure below refers to the percentage of children born as a result of the transfer of an embryo which tested normal upon genetic analysis.
ACHIEVEMENTS OF THE CMR CLINIC
The quality of our centre's work is also attested to by the efficiency of our gamete and embryo cryopreservation programme. High cryopreservation efficiency results in higher embryo survival upon thawing and a higher probability of implantation.
| thawing cycles |
survival |
| 601 | 98% |
The use of advanced clinical and operational methods and state-of-the-art technological support, as well as a highly customised treatment programme, has enabled us to reduce the risk of miscarriage significantly compared to the Italian average.
Our results to date compared with the Italian average in 2020, latest available data.
| CMR | Italian average |
| 21% | 26% |
The clinic's priority is to offer couples safe and effective treatments for both the mother and the unborn child.
The transfer of a single blastocyst, or a euploid blastocyst (in the case of pre-implantation genetic diagnosis), has enabled us to reduce the incidence of multiple pregnancies in comparison to the Italian average. This has been made possible with the aid of fundamental equipment such as the time-lapse incubator and advanced, standardised laboratory methods.
A lower incidence of multiple pregnancy means greater safety for mother and child and a lower risk of complications that this type of pregnancy can cause.
Our results to date compared with the Italian average in 2020, the latest available figures.
| CMR | Italian average |
| 8% | 9% |
CMR, with a view to continuous improvement and in order to guarantee a high standard of quality for its specialist healthcare, has been applying a quality management system to its healthcare processes since 2011, guaranteed by UNI EN ISO 9001-2015 Certification.
According to these principles, the Clinic decided to submit its results and the entire MAR process to the verification of a third-party Certification Body (Certiquality Milano) in application of current Italian and European regulations.